Review
Copyright ©The Author(s) 2021.
World J Clin Cases. Jul 6, 2021; 9(19): 4918-4938
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.4918
Table 1 Gastro-intestinal symptoms (frequency < 30%) and correlation with the clinical course of coronavirus disease 2019
Ref.
No. of patients
Frequency of GI symptoms, n (%)
Diarrhea, n (%)
Nausea or vomiting, n (%)
Loss of appetite, n (%)
Abdominal pain, n (%)
Correlation with worse or better clinical course
Comments/limitations
Jin et al[119]65174 (11.4)53 (8.1)21 (3.2)NoNoYes, worseNot prospective or cohort study
Papa et al[120]343 (8.8)1 (2.9)1 (2.9)No1 (2.9)Yes, betterLimited number of patients, possible underestimation of GI-symptoms and digestive comorbidities
Zheng et al[121]1320192 (14.6)107 (8.1)57 (4.3)62 (4.7)11 (0.8)Yes, worseSingle-center, small sample, mild and common type patients
Ai et al[122]1427 (4.9)6 (4.2)6 (4.2)7 (4.9)6 (4.2)NoThe lowest prevalence
Zhang et al[123]78888 (11.2)NANANoNoYes, worseLaboratory results not included in ordinal logistic regression model
Zhou et al[41]25466 (26)46 (18.1)36 (14.2)No3 (1.2)NoMost cases were clinically confirmed patients, difficulty in assessing clinical outcomes
Lei et al[124]11532 (27.8)14 (12.2)9 (7.83)9 (7.83)NoNoSingle-center, selection bias, patients with mild manifestations excluded, aged patients, follow-up data not provided
Remes-Troche et al[125]11223 (20.5)20 (17.8)8 (7.1)No11 (9.8)NoPossible selection bias
Ramachandran et al[126]15031 (20.6)22 (14.7)16 (10.7)No3 (2)NoPossible selection bias, No test for the presence of SARS-CoV-2 RNA
Aghemo et al[127]29269/245 (28.2)69/255 (27.1)11/274 (4.0)NoNoYes, betterPatients admitted in critical conditions were excluded
Ferm et al[128]892219 (24.6)177 (19.8)239 (26.8)105 (11.8)70 (7.8)NoCollection of data limited by recall bias of both patients and health care professionals
Luo et al[51]1141183 (16)68 (6)134 (11.7)180 (15.8)45 (3.8)NoHospitalized patients, only gastro-intestinal (no respiratory) symptoms